Download PDF
Nuklearmedizin 2002; 41(02): 108-113
DOI: 10.1055/s-0038-1625642
Originalarbeiten – Original Articles
Schattauer GmbH

Lymph node staging in extracranial head and neck cancer with FDG PET – appropriate uptake period and size-dependence of the results

Lymphknotenstaging bei extrakraniellen Kopf-Hals-Malignomen mit FDG PET – optimale Uptake-Zeit und Größenabhängigkeit der Ergebnisse
I. Brink
1   Abteilung Nuklearmedizin (Direktor: Prof. Dr. Dr. Dr. h. c. E. Moser), der Universitätsklinik Freiburg, Deutschland
,
Th. Klenzner
2   Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde (Direktor: Prof. Dr. Dr. h. c. R. Laszig), der Universitätsklinik Freiburg, Deutschland
,
Th. Krause
1   Abteilung Nuklearmedizin (Direktor: Prof. Dr. Dr. Dr. h. c. E. Moser), der Universitätsklinik Freiburg, Deutschland
,
M. Mix
1   Abteilung Nuklearmedizin (Direktor: Prof. Dr. Dr. Dr. h. c. E. Moser), der Universitätsklinik Freiburg, Deutschland
,
U. H. Ross
2   Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde (Direktor: Prof. Dr. Dr. h. c. R. Laszig), der Universitätsklinik Freiburg, Deutschland
,
E. Moser
1   Abteilung Nuklearmedizin (Direktor: Prof. Dr. Dr. Dr. h. c. E. Moser), der Universitätsklinik Freiburg, Deutschland
,
E. U. Nitzsche
1   Abteilung Nuklearmedizin (Direktor: Prof. Dr. Dr. Dr. h. c. E. Moser), der Universitätsklinik Freiburg, Deutschland
› Author Affiliations
Further Information

Publication History

Received: 24 October 2001

in revised form: 27 October 2001

Publication Date:
10 January 2018 (online)

    Permissions and Reprints

Summary

Aim: Identification of a rationale for the appropriate uptake period for static clinical extracranial head and neck PET imaging and evaluation of the diagnostic accuracy of such an optimized FDG PET approach for lymph node staging in the head and neck region. Methods: In a subset of 5 patients, kinetic tumour studies were performed in order to identify the cellular activity plateau phase of FDG accumulation for head and neck cancer. Seventy-eight consecutive patients (11 women, 67 men; mean age ± SD: 55 ± 11 years; range, 36-78 years), presenting with histologically proven squamous cell carcinoma and sonographically detected lymph nodes in 86 neck sides, underwent clinically indicated FDG PET imaging. PET results were compared to those derived from histological examinations and follow-up imaging results after 6 months in order to calculate sensitivity and specificity for lymph node staging. Results: FDG kinetics in head and neck cancer indicate that the cellular activity plateau of FDG accumulation is reached after an uptake period of 90 min. Using this protocol metastatic involvement of neck sides with lymph nodes less than 1 cm in diameter was correctly identified with a sensitivity of 71.4% and a specificity of 92.3%. Sensitivity increased with the lymph node diameter (1.1-1.5 cm 83.3%, 1.6-2.0 cm 100%, > 2 cm 88.9%). Conclusion: The appropriate uptake period for static clinical extracranial head and neck PET imaging that allows measurements in the activity plateau phase is about 90 min. FDG PET may add some significant information regarding metastatic spread into regional lymph nodes.

Zusammenfassung

Ziel: Ermittlung der optimalen Uptake-Zeit für statische onkologische PET-Untersuchungen mit 18F-FDG im Kopf-Hals-Bereich und der diagnostischen Genauigkeit im Lymphknotenstaging dieser Region unter Nutzung dieses optimierten Untersuchungsprotokolls. Methoden: Kinetische Studien zur Identifikation der intrazellulären Aktivitätsplateauphase wurden bei 5 Patienten mit primärem Plattenepithelkarzinom der Kopf-Hals-Region durchgeführt. 78 konsekutive Patienten (11 Frauen, 67 Männer, Alter 36-78 Jahre, ± SD: 55 ± 11 Jahre) mit histologisch gesichertem Plattenepithelkarzinom und sonographisch nachweisbaren Lymphknoten in insgesamt 86 Halsseiten wurden mittels statischer FDG PET untersucht. Die PET-Ergebnisse wurden mit histologischen Befunden und den Ergebnissen klinischer Verlaufskontrollen über wenigstens 6 Monate verglichen. Ergebnisse: In den kinetischen Studien wurde ca. 90 min nach FDG-Injektion ein intratumorales Aktivitäts-plateau erreicht. Unter Anwendung dieser Uptake-Zeit wurden Lymphknotenmetastasen in Halsseiten mit Lymphknoten < 1 cm im Durchmesser mit einer Sensitivität von 71,4% und einer Spezifität von 92,3% nachgewiesen. Die Sensitivität stieg mit dem Lymphknotendurchmesser (1,1-1,5 cm 83,3%, 1,6-2,0 cm 100%, > 2 cm 88,9%). Schlussfolgerungen: Für statische onkologische FDG-PET-Aufnahmen im Kopf-Hals-Bereich ist eine Uptake-Zeit von 90 min, die Messungen in einer Aktivitätsplateauphase erlaubt, empfehlenswert. FDG PET erweist sich als ein hilfreiches Instrument im regionären Lymphknotenstaging dieser Körperregion.

Keywords

Head and neck cancer - lymph node staging - 18F-FDG PET - metastases

Schlüsselwörter

Kopf-Hals-Tumoren - Lymphknotenstaging - 18F-FDG-PET - Metastasen
 

  • References

  • 1 Adams S, Baum RP, Stuckensen T. et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998; 25: 1255-60.
    CrossrefPubMedGoogle Scholar
  • 2 Boerner AR, Weckesser M, Herzog H. et al. Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med 1996; 26: 226-30.
    Google Scholar
  • 3 Braams JW, Pruim J, Freling NJM. et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG PET and MRI. J Nucl Med 1995; 36: 211-6.
    PubMedGoogle Scholar
  • 4 Choi Y, Brunken RC, Hawkins RA. et al. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med 1993; 20: 308-18.
    PubMedGoogle Scholar
  • 5 Di Martino E, Nowak B, Krombach GA. et al. Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET). Laryngorhinootologie 2000; 79: 201-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Eichhorn T, Schroeder HG, Glanz H. et al. Histologically controlled comparison of palpation and real time sonography in the diagnosis of cervical lymph node metastases. Laryng Rhinol Otol 1987; 66: 267-74.
    Google Scholar
  • 7 Farber LA, Benard F, Machtay M. et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 1999; 109: 970-5.
    CrossrefPubMedGoogle Scholar
  • 8 Goerres GW, Haenggeli CA, Allaoua M. et al. Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck. Nuklearmedizin 2000; 39: 246-50.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Hajek PC, Salomonowitz E, Tuerk R. et al. Lymph nodes in the neck. Evaluation with US. Radiology 1986; 158: 739-42.
    CrossrefPubMedGoogle Scholar
  • 10 Hamacher K, Coenen HH, Stöcklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235-8.
    PubMedGoogle Scholar
  • 11 Hamberg LM, Hunter GJ, Alpert NM. et al. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?. J Nucl Med 1994; 35: 1308-12.
    PubMedGoogle Scholar
  • 12 Hanasono MM, Kunda LD, Segall GM. et al. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999; 109: 880-5.
    CrossrefPubMedGoogle Scholar
  • 13 Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Transm Med Imag 1982; 13: 601-9.
    Google Scholar
  • 14 Jabour BA, Choi Y, Hoh CK. et al. Extracranial head and neck: PET imaging with 2-[F-18]-fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993; 186: 27-35.
    CrossrefPubMedGoogle Scholar
  • 15 Keyes Jr JW. SUV: Standard uptake or silly useless value?. J Nucl Med 1995; 36: 1836-9.
    PubMedGoogle Scholar
  • 16 Kitagawa Y, Sadato N, Azuma H. et al. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms. J Nucl Med 1999; 40: 1132-7.
    PubMedGoogle Scholar
  • 17 Kubota K, Itoh M, Ozaki K. et al. Advantage of delayed whole-body FDG-PET imaging for tumor detection. Eur J Nucl Med 2001; 28: 696-703.
    CrossrefPubMedGoogle Scholar
  • 18 Lapela M, Grenman R, Kurki T. et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995; 197: 205-11.
    CrossrefPubMedGoogle Scholar
  • 19 Laubenbacher C, Saumweber D, Wagner-Mans-lau C. et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995; 36: 1747-57.
    PubMedGoogle Scholar
  • 20 Mix M, Nitzsche EU. PISAC: a post-injection method for segmented attenuation correction in whole body PET. J Nucl Med 1999; 40 suppl. 297P.
    Google Scholar
  • 21 Myers LL, Wax MK. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer. J Otolaryngol 1998; 27: 342-7.
    PubMedGoogle Scholar
  • 22 Rege S, Maass A, Chaiken L. et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancer. Cancer 1994; 73: 3047-58.
    CrossrefPubMedGoogle Scholar
  • 23 Reisser C, Haberkorn U, Dimitrakopoulou-Strauss A. et al. Chemotherapeutic management of head and neck malignancies with positron emission tomography. Arch Otolaryngol – Head Neck Surg 1995; 121: 272-6.
    PubMedGoogle Scholar
  • 24 Shanmugaratnam K, Sobin LH. Histologic typing of upper respiratory tract tumours. Geneva: World Health Organisation,; 1978
    Google Scholar
  • 25 Stokkel MP, Terhaard CH, Hordijk GJ. et al. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med 1999; 26: 767-73.
    CrossrefPubMedGoogle Scholar
  • 26 Stomper PC. Cancer imaging manual. Philadelphia: J. B. Lippincott; 1993: 63-86.
    Google Scholar
  • 27 Suen JY, Goepfert A. Standardization of neck dissection nomenclature. Head Neck Surg 1987; 10: 76.
    Google Scholar
  • 28 Van den Brekel MW. Lymph node metastases. CT and MRI. Eur J Radiol 2000; 33: 230-8.
    CrossrefPubMedGoogle Scholar